nylidrin has been researched along with Cognition Disorders in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a dosage of 24 mg daily, it reached its peak effectiveness after 3 months of use." | 2.65 | Efficacy of nylidrin hydrochloride in the treatment of cognitive impairment in the elderly. ( Baron, JJ; Barron, PB; Bjork, AE; Garetz, FK, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garetz, FK | 1 |
| Baron, JJ | 1 |
| Barron, PB | 1 |
| Bjork, AE | 1 |
1 trial available for nylidrin and Cognition Disorders
| Article | Year |
|---|---|
Efficacy of nylidrin hydrochloride in the treatment of cognitive impairment in the elderly.
Topics: Aged; Clinical Trials as Topic; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans; | 1979 |